AdVac tuberculosis vaccine: Preliminary Phase II data

Preliminary data from a double-blind, placebo-controlled, dose-escalation, South African Phase II trial in 72 patients who have completed TB treatment showed that AERAS-402/Crucell Ad35 induced CD8 T...